Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Empirical trials in treatment of gastroesophageal reflux disease.

Fass R.

Dig Dis. 2000;18(1):20-6. Review.

PMID:
10729734
2.

Extraesophageal symptoms: what role for the proton pump inhibitors?

Nord HJ.

Am J Med. 2004 Sep 6;117 Suppl 5A:56S-62S. Review.

PMID:
15478854
3.

Use of proton pump inhibitor as a diagnostic test in NCCP.

Wong WM.

J Gastroenterol Hepatol. 2005 Dec;20 Suppl:S14-7. Review.

PMID:
16359342
4.

The proton pump inhibitor (PPI) test in GERD: does it still have a role?

Gasiorowska A, Fass R.

J Clin Gastroenterol. 2008 Sep;42(8):867-74. doi: 10.1097/MCG.0b013e31816c47ed. Review.

PMID:
18645525
5.

Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain?: a meta-analysis.

Wang WH, Huang JQ, Zheng GF, Wong WM, Lam SK, Karlberg J, Xia HH, Fass R, Wong BC.

Arch Intern Med. 2005 Jun 13;165(11):1222-8. Review.

PMID:
15956000
6.

[Noncardiac chest pain and gastroesophageal reflux disease].

Dimache M, Turcan E, Nătase M.

Rev Med Chir Soc Med Nat Iasi. 2010 Apr-Jun;114(2):342-8. Romanian.

PMID:
20700964
7.

State of the art: extraesophageal manifestations of gastroesophageal reflux disease.

Katz PO.

Rev Gastroenterol Disord. 2005 Summer;5(3):126-34. Review.

PMID:
16127347
8.

The clinical and economic impact of competing management strategies for gastro-oesophageal reflux disease.

Ofman JJ, Dorn GH, Fennerty MB, Fass R.

Aliment Pharmacol Ther. 2002 Feb;16(2):261-73. Review.

9.

Extraesophageal and atypical manifestations of GERD.

Wong WM, Fass R.

J Gastroenterol Hepatol. 2004 Sep;19 Suppl 3:S33-43. Review.

PMID:
15324380
10.

Effect of antisecretory therapy on atypical symptoms in gastroesophageal reflux disease.

Dore MP, Pedroni A, Pes GM, Maragkoudakis E, Tadeu V, Pirina P, Realdi G, Delitala G, Malaty HM.

Dig Dis Sci. 2007 Feb;52(2):463-8. Epub 2007 Jan 9.

PMID:
17211695
11.

[Significance of PPI-test in the diagnosis of GERD].

Takahashi M, Nishiki R, Ichimura H, Takada H, Kuwayama H.

Nihon Rinsho. 2004 Aug;62(8):1465-74. Review. Japanese.

PMID:
15344536
12.

A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.

Gerson LB, Robbins AS, Garber A, Hornberger J, Triadafilopoulos G.

Am J Gastroenterol. 2000 Feb;95(2):395-407.

PMID:
10685741
13.

Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis.

Cremonini F, Wise J, Moayyedi P, Talley NJ.

Am J Gastroenterol. 2005 Jun;100(6):1226-32.

PMID:
15929749
14.

Extra-esophageal disorders in gastroesophageal reflux disease.

Jaspersen D.

Dig Dis. 2004;22(2):115-9. Review.

PMID:
15383751
15.

Noncardiac chest pain.

Katz PO.

Rev Cardiovasc Med. 2005;6 Suppl 4:S32-9. Review.

PMID:
17710075
17.

The cost-effectiveness of the omeprazole test in patients with noncardiac chest pain.

Ofman JJ, Gralnek IM, Udani J, Fennerty MB, Fass R.

Am J Med. 1999 Sep;107(3):219-27.

PMID:
10492314
18.

Noncardiac chest pain.

Botoman VA.

J Clin Gastroenterol. 2002 Jan;34(1):6-14. Review.

PMID:
11743240
19.

[PPI-test].

Takahashi M, Katayama Y, Suzuki K, Tajima A, Oka S, Koizumi K, Ichimura H, Kuwayama H.

Nihon Rinsho. 2007 May;65(5):852-63. Review. Japanese.

PMID:
17511224
20.

Cost-minimization analysis of treatment of gastroesophageal reflux disease. Implications of varying holding time on conclusions.

Kivioja A, Linnosmaa I, Vehviläinen A, Vohlonen I.

Eur J Pharm Sci. 2004 Feb;21(2-3):171-8.

PMID:
14757488

Supplemental Content

Support Center